EzaLife Concludes Equity Crowdfunding Campaign for Medical Device Innovation

EzaLife has entered the final days of its equity crowdfunding campaign on StartEngine, with the raise set to close on April 6. The company developed the FDA-registered Button Huggie® device to address a critical issue impacting over 1 million families annually who rely on feeding tubes. Founded by a pediatric surgeon who witnessed firsthand the limitations of traditional securement methods, Ezalife has built a solution focused on simplicity, safety, and reliability.

Key highlights include a clinically demonstrated 77% reduction in feeding tube dislodgement, early traction with $8,000 in pre-orders and $11,000 in first-month sales, and backing from leading institutions including Children’s Hospital Colorado and CU Innovations. The company has been granted patents with global protection and has future pipeline potential. With momentum building across both clinical and consumer channels, Ezalife is now focused on scaling distribution and expanding access to patients and providers.

Leadership described this as a pivotal moment for the company, stating they have built the foundation and are now focused on growth. Investors have a limited window to participate before the campaign closes through the platform at https://www.startengine.com/offering/ezalife. The device represents a significant advancement in medical technology for tube-fed patients, offering improved security and reliability compared to traditional methods.

The campaign's conclusion marks an important milestone for Ezalife as it transitions from development to broader market implementation. The company's approach addresses a longstanding challenge in pediatric and adult medical care, with potential implications for reducing hospital readmissions and improving quality of life for patients dependent on feeding tubes. The equity crowdfunding model has provided an alternative pathway for medical innovation funding, allowing broader investor participation in healthcare advancements.